| Autor: |
Bonamigo, Renan Rangel, Bottega, Gustavo Borchardt, Staub, Fernanda Luiza, Almeida, Rodrigo Oliveira, Werka, Hellen Meyre Grosskopf |
| Předmět: |
|
| Zdroj: |
International Journal of Dermatology; Mar2022, Vol. 61 Issue 3, p372-374, 3p |
| Abstrakt: |
Could this reaction, particularly if accompanied by vasculitis and thrombosis, be a marker of severe outcomes of SARS-CoV-2 infection? Dear Editor, Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is a drug reaction with well-defined criteria and some clinical and histopathological variability, in addition to simultaneous overlapping features with other pharmacological reactions.1,2 We report a special case of SDRIFE with bullae formation in a patient with severe COVID-19, a situation that is unmatched in the literature. Histopathology showed marked epidermal spongiosis, mild interface dermatitis, and dermal edema, inflammatory infiltrate with eosinophils and leukocytoclastic vasculitis with focal thrombi (Fig. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text